English | Español

Biospace
Patient Daily | Jan 19, 2026

AbbVie licenses RemeGen's cancer drug candidate for nearly $5 billion
Patient Daily | Jan 16, 2026

Vedanta reduces workforce amid focus on phase III C. diff drug trial
Patient Daily | Jan 16, 2026

Protagonist considers opting out of co-development after positive rusfertide trial results
Patient Daily | Jan 16, 2026

Novo Nordisk Foundation commits $850 million for European life sciences innovation
Patient Daily | Jan 16, 2026

Sanofi rumored to consider acquisition bid for Ocular Therapeutix
Patient Daily | Jan 16, 2026

Korro Bio seeks turnaround after clinical setback and staff reductions
Patient Daily | Jan 15, 2026

Biopharma leaders outline key hurdles facing drug manufacturing professionals
Patient Daily | Jan 15, 2026

Jazz sells priority review voucher for record sum amid uncertainty over program renewal

Trending
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
+ Regulatory
A. D. Alderman | Jun 3, 2026

New study says TikTok content may normalize illicit vaping among youth as Trump Administration ramps up enforcement
+ Pharmaceuticals
Patient Daily | Jun 4, 2026

Experts discuss impact of employment gaps in the biopharma job market